

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.01538853 |
| 2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.79348244 |
| 3 | positive regulation of B cell differentiation (GO:0045579) | 5.68546687 |
| 4 | B cell receptor signaling pathway (GO:0050853) | 5.44617608 |
| 5 | regulation of gamma-delta T cell activation (GO:0046643) | 5.17058895 |
| 6 | positive regulation of histone deacetylation (GO:0031065) | 5.03068270 |
| 7 | natural killer cell differentiation (GO:0001779) | 5.01239995 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.88249168 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.88249168 |
| 10 | V(D)J recombination (GO:0033151) | 4.86927176 |
| 11 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.72649535 |
| 12 | positive regulation by host of viral transcription (GO:0043923) | 4.61440351 |
| 13 | serine transport (GO:0032329) | 4.56131279 |
| 14 | L-serine transport (GO:0015825) | 4.47461940 |
| 15 | adaptation of signaling pathway (GO:0023058) | 4.44890959 |
| 16 | cellular hyperosmotic response (GO:0071474) | 4.43471038 |
| 17 | detection of other organism (GO:0098543) | 4.27384613 |
| 18 | regulation of histone H3-K9 methylation (GO:0051570) | 4.26768952 |
| 19 | Peyers patch development (GO:0048541) | 4.25349718 |
| 20 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.25349718 |
| 21 | detection of bacterium (GO:0016045) | 4.24102731 |
| 22 | regulation of B cell differentiation (GO:0045577) | 4.22231185 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 4.17134109 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 4.17134109 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.17134109 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.17134109 |
| 27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.17134109 |
| 28 | modulation by symbiont of host immune response (GO:0052553) | 4.17134109 |
| 29 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.13568168 |
| 30 | protein-DNA complex disassembly (GO:0032986) | 4.10104215 |
| 31 | nucleosome disassembly (GO:0006337) | 4.10104215 |
| 32 | negative regulation of cell killing (GO:0031342) | 3.89801269 |
| 33 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.89801269 |
| 34 | negative regulation of phagocytosis (GO:0050765) | 3.85891072 |
| 35 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.80593214 |
| 36 | tolerance induction (GO:0002507) | 3.79550259 |
| 37 | positive regulation of protein deacetylation (GO:0090312) | 3.75208122 |
| 38 | macrophage activation involved in immune response (GO:0002281) | 3.73152310 |
| 39 | negative regulation of histone methylation (GO:0031061) | 3.70424798 |
| 40 | positive thymic T cell selection (GO:0045059) | 3.63159091 |
| 41 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.61876925 |
| 42 | T cell homeostasis (GO:0043029) | 3.60097199 |
| 43 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.52619828 |
| 44 | T cell migration (GO:0072678) | 3.46074183 |
| 45 | detection of external biotic stimulus (GO:0098581) | 3.39122676 |
| 46 | negative regulation of granulocyte differentiation (GO:0030853) | 3.38885173 |
| 47 | positive regulation of gene expression, epigenetic (GO:0045815) | 3.38141105 |
| 48 | hepatocyte apoptotic process (GO:0097284) | 3.38104885 |
| 49 | germinal center formation (GO:0002467) | 3.34016855 |
| 50 | tachykinin receptor signaling pathway (GO:0007217) | 3.33504443 |
| 51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.33327860 |
| 52 | regulation of superoxide anion generation (GO:0032928) | 3.32239318 |
| 53 | T cell selection (GO:0045058) | 3.31544713 |
| 54 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.30745528 |
| 55 | response to muramyl dipeptide (GO:0032495) | 3.30490429 |
| 56 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.29147813 |
| 57 | pentose-phosphate shunt (GO:0006098) | 3.27738746 |
| 58 | leukocyte aggregation (GO:0070486) | 3.27420503 |
| 59 | negative thymic T cell selection (GO:0045060) | 3.27347274 |
| 60 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.26383205 |
| 61 | negative T cell selection (GO:0043383) | 3.23178439 |
| 62 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.20434305 |
| 63 | lymphocyte homeostasis (GO:0002260) | 3.17763000 |
| 64 | melanin biosynthetic process (GO:0042438) | 3.15783249 |
| 65 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.12555540 |
| 66 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.09786871 |
| 67 | negative regulation of T cell mediated immunity (GO:0002710) | 3.06668658 |
| 68 | response to peptidoglycan (GO:0032494) | 3.06496996 |
| 69 | cellular extravasation (GO:0045123) | 3.05522616 |
| 70 | negative regulation of gene expression, epigenetic (GO:0045814) | 3.05235029 |
| 71 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.04202045 |
| 72 | negative regulation of bone resorption (GO:0045779) | 3.04112001 |
| 73 | chromatin silencing (GO:0006342) | 3.03816690 |
| 74 | regulation of mast cell degranulation (GO:0043304) | 3.03589428 |
| 75 | cellular response to zinc ion (GO:0071294) | 3.03537298 |
| 76 | DNA unwinding involved in DNA replication (GO:0006268) | 3.03067468 |
| 77 | regulation of leukocyte degranulation (GO:0043300) | 3.02362806 |
| 78 | detection of biotic stimulus (GO:0009595) | 3.02178639 |
| 79 | thymic T cell selection (GO:0045061) | 3.02038057 |
| 80 | immunoglobulin mediated immune response (GO:0016064) | 3.00515148 |
| 81 | regulation of granulocyte differentiation (GO:0030852) | 3.00114581 |
| 82 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.99965735 |
| 83 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.96573705 |
| 84 | positive regulation of Rap GTPase activity (GO:0032854) | 2.94867935 |
| 85 | lens fiber cell development (GO:0070307) | 2.94787877 |
| 86 | embryonic hemopoiesis (GO:0035162) | 2.94164949 |
| 87 | positive regulation of lamellipodium assembly (GO:0010592) | 2.93857645 |
| 88 | histone H3-K36 demethylation (GO:0070544) | 2.92935820 |
| 89 | regulation of T cell tolerance induction (GO:0002664) | 2.88365496 |
| 90 | regulation of ARF protein signal transduction (GO:0032012) | 2.87757773 |
| 91 | regulation of extracellular matrix disassembly (GO:0010715) | 2.87256012 |
| 92 | melanin metabolic process (GO:0006582) | 2.86552276 |
| 93 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.86071472 |
| 94 | regulation of tolerance induction (GO:0002643) | 2.83981718 |
| 95 | natural killer cell activation (GO:0030101) | 2.82435005 |
| 96 | respiratory burst (GO:0045730) | 2.80176215 |
| 97 | germ cell migration (GO:0008354) | 2.79871419 |
| 98 | positive regulation of granulocyte differentiation (GO:0030854) | 2.78696841 |
| 99 | neutrophil activation (GO:0042119) | 2.78679739 |
| 100 | leukocyte homeostasis (GO:0001776) | 2.77541823 |
| 101 | cellular response to interleukin-15 (GO:0071350) | 2.76184290 |
| 102 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.75656950 |
| 103 | response to interleukin-15 (GO:0070672) | 2.75374798 |
| 104 | positive T cell selection (GO:0043368) | 2.75215831 |
| 105 | cellular response to osmotic stress (GO:0071470) | 2.74275667 |
| 106 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.74209864 |
| 107 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.73803732 |
| 108 | detection of molecule of bacterial origin (GO:0032490) | 2.73703017 |
| 109 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.72500151 |
| 110 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.72500151 |
| 111 | regulation of necroptotic process (GO:0060544) | 2.72101162 |
| 112 | cortical actin cytoskeleton organization (GO:0030866) | 2.70801669 |
| 113 | myeloid cell activation involved in immune response (GO:0002275) | 2.70788269 |
| 114 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.70332723 |
| 115 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.70272503 |
| 116 | T cell receptor signaling pathway (GO:0050852) | 2.70270128 |
| 117 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.70159379 |
| 118 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.69642705 |
| 119 | response to host immune response (GO:0052572) | 2.69642705 |
| 120 | activated T cell proliferation (GO:0050798) | 2.69452016 |
| 121 | regulation of Rap GTPase activity (GO:0032317) | 2.69287588 |
| 122 | NADPH regeneration (GO:0006740) | 2.68657001 |
| 123 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.68562441 |
| 124 | negative regulation of type 2 immune response (GO:0002829) | 2.66411345 |
| 125 | T cell costimulation (GO:0031295) | 2.65170623 |
| 126 | defense response to protozoan (GO:0042832) | 2.65114558 |
| 127 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.63909492 |
| 128 | negative regulation of interleukin-12 production (GO:0032695) | 2.63891342 |
| 129 | regulation of histone deacetylation (GO:0031063) | 2.63374528 |
| 130 | negative regulation of stress fiber assembly (GO:0051497) | 2.63083831 |
| 131 | regulation of antigen processing and presentation (GO:0002577) | 2.62776926 |
| 132 | B cell homeostasis (GO:0001782) | 2.61894348 |
| 133 | response to host (GO:0075136) | 2.61595647 |
| 134 | response to host defenses (GO:0052200) | 2.61595647 |
| 135 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.61595647 |
| 136 | erythrocyte differentiation (GO:0030218) | 2.61248653 |
| 137 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.60066518 |
| 138 | histone H3-K9 demethylation (GO:0033169) | 2.59998492 |
| 139 | response to type I interferon (GO:0034340) | 2.59540214 |
| 140 | type I interferon signaling pathway (GO:0060337) | 2.58965288 |
| 141 | cellular response to type I interferon (GO:0071357) | 2.58965288 |
| 142 | myeloid dendritic cell activation (GO:0001773) | 2.58537103 |
| 143 | lymphocyte costimulation (GO:0031294) | 2.57811360 |
| 144 | chromatin assembly (GO:0031497) | 2.56242778 |
| 145 | activation of JUN kinase activity (GO:0007257) | 2.55907220 |
| 146 | protein localization to endosome (GO:0036010) | 2.55262051 |
| 147 | establishment of endothelial barrier (GO:0061028) | 2.55022759 |
| 148 | vesicle targeting (GO:0006903) | 2.53458497 |
| 149 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.53228890 |
| 150 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.52636246 |
| 151 | neutrophil activation involved in immune response (GO:0002283) | 2.52177673 |
| 152 | mannose metabolic process (GO:0006013) | 2.49358584 |
| 153 | granulocyte activation (GO:0036230) | 2.49018955 |
| 154 | NIK/NF-kappaB signaling (GO:0038061) | 2.47818868 |
| 155 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.47054583 |
| 156 | erythrocyte maturation (GO:0043249) | 2.47019479 |
| 157 | regulation of erythrocyte differentiation (GO:0045646) | 2.46705014 |
| 158 | positive regulation of interleukin-2 production (GO:0032743) | 2.46403902 |
| 159 | response to laminar fluid shear stress (GO:0034616) | 2.46379373 |
| 160 | positive regulation of lamellipodium organization (GO:1902745) | 2.46377756 |
| 161 | myeloid dendritic cell differentiation (GO:0043011) | 2.45868517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.18751921 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 4.36640900 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.82521128 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.65470755 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.49955434 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.35643490 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.22843526 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.04931851 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.95080548 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.85330921 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.75872625 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.73126429 |
| 13 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.67328788 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.63793721 |
| 15 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.52633421 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.51950032 |
| 17 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.49570918 |
| 18 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.46950568 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.44537415 |
| 20 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.44068291 |
| 21 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.40383901 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.37506997 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.33408400 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.27323118 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.23493261 |
| 26 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.19357891 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.13377373 |
| 28 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.12862384 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 2.12786336 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 2.08150129 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.00698019 |
| 32 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.99866610 |
| 33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.89740208 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.85054149 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.82840721 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.75847643 |
| 37 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.74566386 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74401554 |
| 39 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.72689127 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.70823962 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69002660 |
| 42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.67641569 |
| 43 | GATA1_19941826_ChIP-Seq_K562_Human | 1.67182844 |
| 44 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.64027618 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.63039768 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.62182755 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.61025140 |
| 48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.60930503 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.58660671 |
| 50 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.55092093 |
| 51 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.54074476 |
| 52 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.48238381 |
| 53 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.48227184 |
| 54 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.46733294 |
| 55 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.45863101 |
| 56 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.45280270 |
| 57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.43396910 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.43214533 |
| 59 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.42632263 |
| 60 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41438147 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37943975 |
| 62 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.34038594 |
| 63 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.33414369 |
| 64 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.31300093 |
| 65 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.29629166 |
| 66 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29310226 |
| 67 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.27752831 |
| 68 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.26690248 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26458344 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24277857 |
| 71 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.24171361 |
| 72 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22935311 |
| 73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.21120728 |
| 74 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18462582 |
| 75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16639439 |
| 76 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14786355 |
| 77 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.14073852 |
| 78 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13749881 |
| 79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12535851 |
| 80 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.12497077 |
| 81 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11610981 |
| 82 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09451854 |
| 83 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07629568 |
| 84 | GATA2_19941826_ChIP-Seq_K562_Human | 1.07096198 |
| 85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06954321 |
| 86 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06661294 |
| 87 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04156811 |
| 88 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03927077 |
| 89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03110899 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02954669 |
| 91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02734543 |
| 92 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02306312 |
| 93 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01388921 |
| 94 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.99972865 |
| 95 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.99739501 |
| 96 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.99117292 |
| 97 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.97610042 |
| 98 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.96601687 |
| 99 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.95899861 |
| 100 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.95114175 |
| 101 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94695922 |
| 102 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.93794939 |
| 103 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.93790757 |
| 104 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91681744 |
| 105 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89405798 |
| 106 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88083451 |
| 107 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87200343 |
| 108 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87120615 |
| 109 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87061447 |
| 110 | P68_20966046_ChIP-Seq_HELA_Human | 0.87004149 |
| 111 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.86918748 |
| 112 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86177561 |
| 113 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85765984 |
| 114 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84323054 |
| 115 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84301969 |
| 116 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.84158130 |
| 117 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.84129781 |
| 118 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84106249 |
| 119 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83965827 |
| 120 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.83068282 |
| 121 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81869669 |
| 122 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81581063 |
| 123 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.81255596 |
| 124 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.79243138 |
| 125 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.78848398 |
| 126 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77986901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000685_abnormal_immune_system | 3.52173832 |
| 2 | MP0002396_abnormal_hematopoietic_system | 2.98529879 |
| 3 | MP0003724_increased_susceptibility_to | 2.90882067 |
| 4 | MP0001800_abnormal_humoral_immune | 2.90532439 |
| 5 | MP0002166_altered_tumor_susceptibility | 2.77241814 |
| 6 | MP0009278_abnormal_bone_marrow | 2.62228065 |
| 7 | MP0005387_immune_system_phenotype | 2.58126474 |
| 8 | MP0001790_abnormal_immune_system | 2.58126474 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.57007728 |
| 10 | MP0002398_abnormal_bone_marrow | 2.56058300 |
| 11 | MP0005451_abnormal_body_composition | 2.51115939 |
| 12 | MP0004808_abnormal_hematopoietic_stem | 2.36974234 |
| 13 | MP0008260_abnormal_autophagy | 2.36615314 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.35791527 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.34378502 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.32235506 |
| 17 | MP0005671_abnormal_response_to | 2.26378900 |
| 18 | MP0003303_peritoneal_inflammation | 2.25853371 |
| 19 | MP0003172_abnormal_lysosome_physiology | 2.22313854 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.20530237 |
| 21 | MP0000689_abnormal_spleen_morphology | 2.19640552 |
| 22 | MP0001819_abnormal_immune_cell | 2.17013813 |
| 23 | MP0000703_abnormal_thymus_morphology | 2.15844709 |
| 24 | MP0002722_abnormal_immune_system | 2.13717881 |
| 25 | MP0003436_decreased_susceptibility_to | 2.12814523 |
| 26 | MP0000716_abnormal_immune_system | 2.10226394 |
| 27 | MP0002723_abnormal_immune_serum | 2.08562129 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 2.02558416 |
| 29 | MP0006054_spinal_hemorrhage | 1.99900154 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 1.92382869 |
| 31 | MP0001545_abnormal_hematopoietic_system | 1.92382869 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.85704095 |
| 33 | MP0002429_abnormal_blood_cell | 1.82808593 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.81095237 |
| 35 | MP0009785_altered_susceptibility_to | 1.77971282 |
| 36 | MP0002006_tumorigenesis | 1.76143808 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.70194341 |
| 38 | MP0005409_darkened_coat_color | 1.66631973 |
| 39 | MP0004947_skin_inflammation | 1.65004166 |
| 40 | MP0005025_abnormal_response_to | 1.63099626 |
| 41 | MP0001873_stomach_inflammation | 1.62878990 |
| 42 | MP0002405_respiratory_system_inflammati | 1.60584218 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.56340331 |
| 44 | MP0003828_pulmonary_edema | 1.54108642 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.53911650 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.49774228 |
| 47 | MP0002095_abnormal_skin_pigmentation | 1.49440348 |
| 48 | MP0000372_irregular_coat_pigmentation | 1.47479677 |
| 49 | MP0010094_abnormal_chromosome_stability | 1.46517680 |
| 50 | MP0005076_abnormal_cell_differentiation | 1.45302938 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.44608599 |
| 52 | MP0002419_abnormal_innate_immunity | 1.40381589 |
| 53 | MP0009840_abnormal_foam_cell | 1.40125943 |
| 54 | MP0002019_abnormal_tumor_incidence | 1.35735506 |
| 55 | MP0002148_abnormal_hypersensitivity_rea | 1.32197112 |
| 56 | MP0004185_abnormal_adipocyte_glucose | 1.31987246 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 1.30656919 |
| 58 | MP0003690_abnormal_glial_cell | 1.29995629 |
| 59 | MP0003866_abnormal_defecation | 1.29246232 |
| 60 | MP0000490_abnormal_crypts_of | 1.27914363 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.27294392 |
| 62 | MP0010352_gastrointestinal_tract_polyps | 1.24984423 |
| 63 | MP0004381_abnormal_hair_follicle | 1.24760382 |
| 64 | MP0002933_joint_inflammation | 1.20335613 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.18358343 |
| 66 | MP0002132_abnormal_respiratory_system | 1.18227586 |
| 67 | MP0005670_abnormal_white_adipose | 1.15771235 |
| 68 | MP0000858_altered_metastatic_potential | 1.14232476 |
| 69 | MP0005666_abnormal_adipose_tissue | 1.12782340 |
| 70 | MP0010307_abnormal_tumor_latency | 1.12345067 |
| 71 | MP0000371_diluted_coat_color | 1.08175716 |
| 72 | MP0004130_abnormal_muscle_cell | 1.07634553 |
| 73 | MP0005171_absent_coat_pigmentation | 1.06937641 |
| 74 | MP0003111_abnormal_nucleus_morphology | 1.05482384 |
| 75 | MP0005174_abnormal_tail_pigmentation | 1.04470744 |
| 76 | MP0001845_abnormal_inflammatory_respons | 1.03994062 |
| 77 | MP0003045_fibrosis | 1.03508107 |
| 78 | MP0000015_abnormal_ear_pigmentation | 1.01778163 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 1.01537949 |
| 80 | MP0003077_abnormal_cell_cycle | 0.99933402 |
| 81 | MP0004147_increased_porphyrin_level | 0.99720435 |
| 82 | MP0005375_adipose_tissue_phenotype | 0.97121567 |
| 83 | MP0002877_abnormal_melanocyte_morpholog | 0.93446392 |
| 84 | MP0006082_CNS_inflammation | 0.92704933 |
| 85 | MP0005166_decreased_susceptibility_to | 0.92317398 |
| 86 | MP0008469_abnormal_protein_level | 0.91691252 |
| 87 | MP0001879_abnormal_lymphatic_vessel | 0.91252453 |
| 88 | MP0002009_preneoplasia | 0.89991523 |
| 89 | MP0003011_delayed_dark_adaptation | 0.89687744 |
| 90 | MP0003566_abnormal_cell_adhesion | 0.88052480 |
| 91 | MP0004510_myositis | 0.87589973 |
| 92 | MP0003329_amyloid_beta_deposits | 0.86243978 |
| 93 | MP0005075_abnormal_melanosome_morpholog | 0.85926469 |
| 94 | MP0004883_abnormal_blood_vessel | 0.84807841 |
| 95 | MP0000604_amyloidosis | 0.84606501 |
| 96 | MP0002970_abnormal_white_adipose | 0.82797480 |
| 97 | MP0001851_eye_inflammation | 0.81810271 |
| 98 | MP0005310_abnormal_salivary_gland | 0.80820330 |
| 99 | MP0001663_abnormal_digestive_system | 0.79984929 |
| 100 | MP0000003_abnormal_adipose_tissue | 0.79601049 |
| 101 | MP0001533_abnormal_skeleton_physiology | 0.79120588 |
| 102 | MP0004858_abnormal_nervous_system | 0.78877944 |
| 103 | MP0002075_abnormal_coat/hair_pigmentati | 0.78546760 |
| 104 | MP0010630_abnormal_cardiac_muscle | 0.77626259 |
| 105 | MP0000733_abnormal_muscle_development | 0.77374390 |
| 106 | MP0003646_muscle_fatigue | 0.75194430 |
| 107 | MP0009931_abnormal_skin_appearance | 0.74810598 |
| 108 | MP0008770_decreased_survivor_rate | 0.74283528 |
| 109 | MP0005058_abnormal_lysosome_morphology | 0.73905084 |
| 110 | MP0000350_abnormal_cell_proliferation | 0.72440515 |
| 111 | MP0001853_heart_inflammation | 0.71981630 |
| 112 | MP0005551_abnormal_eye_electrophysiolog | 0.71689889 |
| 113 | MP0003091_abnormal_cell_migration | 0.71566844 |
| 114 | MP0005501_abnormal_skin_physiology | 0.71285653 |
| 115 | MP0003950_abnormal_plasma_membrane | 0.70783704 |
| 116 | MP0001986_abnormal_taste_sensitivity | 0.70644187 |
| 117 | MP0001915_intracranial_hemorrhage | 0.70576168 |
| 118 | MP0001324_abnormal_eye_pigmentation | 0.70147605 |
| 119 | MP0003075_altered_response_to | 0.69914574 |
| 120 | MP0000249_abnormal_blood_vessel | 0.69580640 |
| 121 | MP0008874_decreased_physiological_sensi | 0.69485576 |
| 122 | MP0004233_abnormal_muscle_weight | 0.69375213 |
| 123 | MP0001849_ear_inflammation | 0.69278223 |
| 124 | MP0009115_abnormal_fat_cell | 0.67439330 |
| 125 | MP0010234_abnormal_vibrissa_follicle | 0.64674634 |
| 126 | MP0004264_abnormal_extraembryonic_tissu | 0.61675288 |
| 127 | MP0002971_abnormal_brown_adipose | 0.61235902 |
| 128 | MP0000747_muscle_weakness | 0.59936471 |
| 129 | MP0008004_abnormal_stomach_pH | 0.59878969 |
| 130 | MP0008569_lethality_at_weaning | 0.56000038 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 6.59465550 |
| 2 | Verrucae (HP:0200043) | 6.35210809 |
| 3 | Papilloma (HP:0012740) | 6.35210809 |
| 4 | Cellulitis (HP:0100658) | 6.07153101 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.65703138 |
| 6 | Thyroiditis (HP:0100646) | 5.06976691 |
| 7 | B lymphocytopenia (HP:0010976) | 4.99558745 |
| 8 | Abnormality of B cell number (HP:0010975) | 4.99558745 |
| 9 | Panhypogammaglobulinemia (HP:0003139) | 4.67359517 |
| 10 | Recurrent viral infections (HP:0004429) | 4.54686416 |
| 11 | Severe combined immunodeficiency (HP:0004430) | 4.23465134 |
| 12 | T lymphocytopenia (HP:0005403) | 4.19054050 |
| 13 | Recurrent bronchitis (HP:0002837) | 4.10429821 |
| 14 | Combined immunodeficiency (HP:0005387) | 4.04189239 |
| 15 | Abnormality of T cell number (HP:0011839) | 3.88472221 |
| 16 | Meningitis (HP:0001287) | 3.76648678 |
| 17 | Hypoplasia of the thymus (HP:0000778) | 3.69945466 |
| 18 | Colitis (HP:0002583) | 3.69254269 |
| 19 | Abnormality of the fingertips (HP:0001211) | 3.63299672 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.63249530 |
| 21 | Inflammation of the large intestine (HP:0002037) | 3.62036164 |
| 22 | Gastrointestinal inflammation (HP:0004386) | 3.61772454 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.59431450 |
| 24 | Chronic otitis media (HP:0000389) | 3.58998370 |
| 25 | Osteomyelitis (HP:0002754) | 3.56870073 |
| 26 | Myositis (HP:0100614) | 3.43135601 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 3.38662105 |
| 28 | Abnormality of the intervertebral disk (HP:0005108) | 3.38536363 |
| 29 | Vertebral arch anomaly (HP:0008438) | 3.26744317 |
| 30 | Sepsis (HP:0100806) | 3.25334010 |
| 31 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.24918099 |
| 32 | Gastrointestinal infarctions (HP:0005244) | 3.21448658 |
| 33 | Spontaneous hematomas (HP:0007420) | 3.13086346 |
| 34 | Small epiphyses (HP:0010585) | 3.07992035 |
| 35 | Gingivitis (HP:0000230) | 3.01622512 |
| 36 | Obstructive lung disease (HP:0006536) | 3.00050296 |
| 37 | Chronic obstructive pulmonary disease (HP:0006510) | 3.00050296 |
| 38 | Orchitis (HP:0100796) | 2.96111043 |
| 39 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.95322129 |
| 40 | Chronic sinusitis (HP:0011109) | 2.94823429 |
| 41 | Hyperacusis (HP:0010780) | 2.86212056 |
| 42 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.85219944 |
| 43 | Abnormality of T cells (HP:0002843) | 2.85151128 |
| 44 | Eosinophilia (HP:0001880) | 2.78592021 |
| 45 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.74797590 |
| 46 | IgM deficiency (HP:0002850) | 2.74360303 |
| 47 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.70999460 |
| 48 | Obstructive sleep apnea (HP:0002870) | 2.69754529 |
| 49 | Autoimmune thrombocytopenia (HP:0001973) | 2.66367607 |
| 50 | Retrobulbar optic neuritis (HP:0100654) | 2.65002939 |
| 51 | Optic neuritis (HP:0100653) | 2.65002939 |
| 52 | Ulnar bowing (HP:0003031) | 2.63156505 |
| 53 | Fatigue (HP:0012378) | 2.58022161 |
| 54 | Long eyelashes (HP:0000527) | 2.57999176 |
| 55 | Abnormality of the nasal mucosa (HP:0000433) | 2.57966498 |
| 56 | Nasal polyposis (HP:0100582) | 2.53815995 |
| 57 | Recurrent sinusitis (HP:0011108) | 2.52694909 |
| 58 | Encephalitis (HP:0002383) | 2.52579474 |
| 59 | Viral hepatitis (HP:0006562) | 2.47506965 |
| 60 | Recurrent otitis media (HP:0000403) | 2.45267122 |
| 61 | Lymphopenia (HP:0001888) | 2.39975861 |
| 62 | Abnormality of eosinophils (HP:0001879) | 2.39030682 |
| 63 | Slow saccadic eye movements (HP:0000514) | 2.37064653 |
| 64 | Difficulty running (HP:0009046) | 2.35157045 |
| 65 | Stomatitis (HP:0010280) | 2.34914084 |
| 66 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.33379784 |
| 67 | Urticaria (HP:0001025) | 2.32332605 |
| 68 | Cutis marmorata (HP:0000965) | 2.31924335 |
| 69 | Pustule (HP:0200039) | 2.30028726 |
| 70 | Hypoproteinemia (HP:0003075) | 2.29263559 |
| 71 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.29048152 |
| 72 | IgG deficiency (HP:0004315) | 2.28797866 |
| 73 | Skin rash (HP:0000988) | 2.26353459 |
| 74 | Granulocytopenia (HP:0001913) | 2.24310269 |
| 75 | Bronchitis (HP:0012387) | 2.24118100 |
| 76 | Increased IgE level (HP:0003212) | 2.23769951 |
| 77 | Hypochromic anemia (HP:0001931) | 2.23701025 |
| 78 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.22142630 |
| 79 | Interstitial pulmonary disease (HP:0006530) | 2.21087564 |
| 80 | Hematochezia (HP:0002573) | 2.20145729 |
| 81 | Congenital stationary night blindness (HP:0007642) | 2.18268463 |
| 82 | Exercise-induced myalgia (HP:0003738) | 2.17980462 |
| 83 | Mitral stenosis (HP:0001718) | 2.16906123 |
| 84 | Poikilocytosis (HP:0004447) | 2.16465516 |
| 85 | Restrictive lung disease (HP:0002091) | 2.13528247 |
| 86 | Polycythemia (HP:0001901) | 2.12411965 |
| 87 | Keratoconjunctivitis sicca (HP:0001097) | 2.11419609 |
| 88 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.11269764 |
| 89 | Recurrent cutaneous fungal infections (HP:0011370) | 2.11269764 |
| 90 | Recurrent pneumonia (HP:0006532) | 2.09584483 |
| 91 | Flattened epiphyses (HP:0003071) | 2.09482337 |
| 92 | Papilledema (HP:0001085) | 2.08497932 |
| 93 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.07371875 |
| 94 | Gastrointestinal stroma tumor (HP:0100723) | 2.05215009 |
| 95 | Epistaxis (HP:0000421) | 2.05193210 |
| 96 | Acute lymphatic leukemia (HP:0006721) | 2.04764202 |
| 97 | Cutaneous melanoma (HP:0012056) | 2.03188192 |
| 98 | Leukocytosis (HP:0001974) | 2.00930240 |
| 99 | Pulmonary infiltrates (HP:0002113) | 2.00610251 |
| 100 | Subacute progressive viral hepatitis (HP:0006572) | 1.99847894 |
| 101 | Pigmentary retinal degeneration (HP:0001146) | 1.94459363 |
| 102 | Ocular albinism (HP:0001107) | 1.93630443 |
| 103 | Skin ulcer (HP:0200042) | 1.93554464 |
| 104 | Prolonged bleeding time (HP:0003010) | 1.92651218 |
| 105 | Increased variability in muscle fiber diameter (HP:0003557) | 1.92433714 |
| 106 | Broad face (HP:0000283) | 1.90872207 |
| 107 | Macroorchidism (HP:0000053) | 1.89600317 |
| 108 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.88938980 |
| 109 | Hypochromic microcytic anemia (HP:0004840) | 1.88494949 |
| 110 | Limited elbow extension (HP:0001377) | 1.86119660 |
| 111 | Recurrent abscess formation (HP:0002722) | 1.85823591 |
| 112 | Metaphyseal cupping (HP:0003021) | 1.85541536 |
| 113 | Hemoptysis (HP:0002105) | 1.85224767 |
| 114 | Pulmonary embolism (HP:0002204) | 1.85098412 |
| 115 | Arterial thrombosis (HP:0004420) | 1.84035433 |
| 116 | Insomnia (HP:0100785) | 1.83840372 |
| 117 | Recurrent lower respiratory tract infections (HP:0002783) | 1.83839702 |
| 118 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.82787847 |
| 119 | Malnutrition (HP:0004395) | 1.81918463 |
| 120 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.81260232 |
| 121 | Increased density of long bones (HP:0006392) | 1.80992032 |
| 122 | Keratoconjunctivitis (HP:0001096) | 1.80876152 |
| 123 | Increased connective tissue (HP:0009025) | 1.80266764 |
| 124 | Germ cell neoplasia (HP:0100728) | 1.80090549 |
| 125 | Toxemia of pregnancy (HP:0100603) | 1.78981881 |
| 126 | Abnormality of the peritoneum (HP:0002585) | 1.77436616 |
| 127 | Gingival bleeding (HP:0000225) | 1.77071782 |
| 128 | Hyporeflexia of lower limbs (HP:0002600) | 1.77041828 |
| 129 | Abnormality of T cell physiology (HP:0011840) | 1.75932941 |
| 130 | Basal cell carcinoma (HP:0002671) | 1.75493470 |
| 131 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.74252895 |
| 132 | Thrombocytosis (HP:0001894) | 1.73890682 |
| 133 | Emphysema (HP:0002097) | 1.73311771 |
| 134 | Polygenic inheritance (HP:0010982) | 1.73183998 |
| 135 | Asymmetric septal hypertrophy (HP:0001670) | 1.72449983 |
| 136 | Microcytic anemia (HP:0001935) | 1.71690615 |
| 137 | Distal lower limb muscle weakness (HP:0009053) | 1.69887311 |
| 138 | Increased cerebral lipofuscin (HP:0011813) | 1.69672626 |
| 139 | Purpura (HP:0000979) | 1.69579401 |
| 140 | Ankle clonus (HP:0011448) | 1.68437209 |
| 141 | Cerebral aneurysm (HP:0004944) | 1.68243429 |
| 142 | Chest pain (HP:0100749) | 1.67365034 |
| 143 | Muscle fiber splitting (HP:0003555) | 1.67178039 |
| 144 | Volvulus (HP:0002580) | 1.65945039 |
| 145 | Recurrent bacterial skin infections (HP:0005406) | 1.65404686 |
| 146 | Albinism (HP:0001022) | 1.65307852 |
| 147 | Lymphoma (HP:0002665) | 1.63391130 |
| 148 | Recurrent skin infections (HP:0001581) | 1.61085645 |
| 149 | Abnormality of the thymus (HP:0000777) | 1.60158399 |
| 150 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.60078215 |
| 151 | Absent epiphyses (HP:0010577) | 1.60078215 |
| 152 | Vasculitis (HP:0002633) | 1.58671223 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 7.72168537 |
| 2 | PRPF4B | 4.13400821 |
| 3 | EEF2K | 3.99733944 |
| 4 | MAP4K1 | 3.16992984 |
| 5 | TRIB3 | 2.95015557 |
| 6 | ERN1 | 2.86080830 |
| 7 | GRK6 | 2.66225844 |
| 8 | PKN2 | 2.49340229 |
| 9 | CDK12 | 2.27864401 |
| 10 | SMG1 | 2.11194001 |
| 11 | STK10 | 2.09076928 |
| 12 | STK4 | 1.88438881 |
| 13 | SIK2 | 1.86441805 |
| 14 | IRAK4 | 1.78670743 |
| 15 | NEK2 | 1.58012664 |
| 16 | TYK2 | 1.53926116 |
| 17 | CLK1 | 1.50109631 |
| 18 | CDK4 | 1.49184263 |
| 19 | BTK | 1.46820136 |
| 20 | TLK1 | 1.44573536 |
| 21 | SYK | 1.38698415 |
| 22 | MAP3K3 | 1.36135349 |
| 23 | CAMK1D | 1.34439095 |
| 24 | LRRK2 | 1.33957320 |
| 25 | KSR2 | 1.33558489 |
| 26 | MAP3K11 | 1.31758591 |
| 27 | ZAP70 | 1.31120505 |
| 28 | MAP3K7 | 1.30794300 |
| 29 | CSF1R | 1.24861905 |
| 30 | MAP3K1 | 1.20065489 |
| 31 | SIK3 | 1.14627254 |
| 32 | CDK9 | 1.13337640 |
| 33 | SIK1 | 1.13021287 |
| 34 | MARK3 | 1.12840585 |
| 35 | JAK3 | 1.10253509 |
| 36 | MAPK12 | 1.10107303 |
| 37 | MAPK11 | 1.09904969 |
| 38 | JAK1 | 1.09807980 |
| 39 | ITK | 1.06197877 |
| 40 | PIM1 | 1.05432887 |
| 41 | CAMK1G | 1.05368073 |
| 42 | HCK | 1.04840289 |
| 43 | RPS6KB2 | 1.02941342 |
| 44 | EPHB1 | 1.01898323 |
| 45 | MAP3K14 | 1.01826184 |
| 46 | HIPK2 | 1.01662239 |
| 47 | BLK | 1.01530401 |
| 48 | MST1R | 0.99527027 |
| 49 | BMX | 0.99516854 |
| 50 | TGFBR2 | 0.99308915 |
| 51 | PDPK1 | 0.98043514 |
| 52 | CAMKK1 | 0.97843992 |
| 53 | MARK2 | 0.97348032 |
| 54 | CDC42BPA | 0.96878317 |
| 55 | FGFR3 | 0.94676445 |
| 56 | FES | 0.93903807 |
| 57 | TBK1 | 0.93687370 |
| 58 | FGFR4 | 0.92670880 |
| 59 | PTK6 | 0.90831311 |
| 60 | LCK | 0.86618275 |
| 61 | TAOK2 | 0.86343741 |
| 62 | FGFR2 | 0.85558368 |
| 63 | CDK6 | 0.85123951 |
| 64 | ICK | 0.83324940 |
| 65 | DYRK1B | 0.80204840 |
| 66 | CSK | 0.80178468 |
| 67 | IRAK2 | 0.78784644 |
| 68 | SCYL2 | 0.77704331 |
| 69 | TXK | 0.77148524 |
| 70 | FGR | 0.76477600 |
| 71 | RPS6KL1 | 0.74985928 |
| 72 | RPS6KC1 | 0.74985928 |
| 73 | MAPK4 | 0.73734512 |
| 74 | TESK2 | 0.73444890 |
| 75 | NLK | 0.72701296 |
| 76 | MAP3K2 | 0.72661621 |
| 77 | TNK2 | 0.72501197 |
| 78 | RIPK1 | 0.71697143 |
| 79 | MAP2K2 | 0.70726444 |
| 80 | IKBKE | 0.69955564 |
| 81 | RIPK4 | 0.69886124 |
| 82 | MELK | 0.69465882 |
| 83 | PRKD1 | 0.68986556 |
| 84 | MAP3K6 | 0.68425233 |
| 85 | MAP2K3 | 0.68406619 |
| 86 | LYN | 0.66681866 |
| 87 | TRPM7 | 0.66630388 |
| 88 | MAP3K8 | 0.66151018 |
| 89 | RPS6KA2 | 0.65483197 |
| 90 | MAPKAPK3 | 0.64713148 |
| 91 | TTN | 0.63646801 |
| 92 | BRD4 | 0.63106539 |
| 93 | PRKD2 | 0.62969957 |
| 94 | MAPK7 | 0.62308199 |
| 95 | PRKD3 | 0.60813506 |
| 96 | FLT3 | 0.59373840 |
| 97 | JAK2 | 0.59197242 |
| 98 | PRKCH | 0.57890432 |
| 99 | RPS6KA6 | 0.57104071 |
| 100 | WNK1 | 0.56466095 |
| 101 | PRKAA2 | 0.54950629 |
| 102 | STK11 | 0.54785494 |
| 103 | SGK3 | 0.54567956 |
| 104 | YES1 | 0.51108205 |
| 105 | SGK2 | 0.48894520 |
| 106 | RPS6KA4 | 0.47987254 |
| 107 | CDC7 | 0.46800846 |
| 108 | CAMK4 | 0.46599400 |
| 109 | IRAK1 | 0.45410415 |
| 110 | PDK1 | 0.44644325 |
| 111 | MTOR | 0.43768675 |
| 112 | UHMK1 | 0.43215139 |
| 113 | BMPR2 | 0.42534077 |
| 114 | PIK3CG | 0.42438919 |
| 115 | DMPK | 0.41979903 |
| 116 | KDR | 0.40078481 |
| 117 | MAPKAPK2 | 0.40008081 |
| 118 | PKN1 | 0.39579896 |
| 119 | IKBKB | 0.38262911 |
| 120 | TYRO3 | 0.37145707 |
| 121 | TEC | 0.37073821 |
| 122 | RPS6KA5 | 0.36914905 |
| 123 | RET | 0.36220441 |
| 124 | PRKAA1 | 0.35409938 |
| 125 | KIT | 0.35061871 |
| 126 | PDGFRB | 0.34774369 |
| 127 | CSNK1D | 0.33885059 |
| 128 | PRKCQ | 0.33646685 |
| 129 | TAOK1 | 0.33583519 |
| 130 | FYN | 0.32736451 |
| 131 | CHUK | 0.30108106 |
| 132 | DYRK3 | 0.30059555 |
| 133 | MAP3K13 | 0.27264058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.86275864 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.68162409 |
| 3 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.56233003 |
| 4 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.46037431 |
| 5 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.10379465 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.98635654 |
| 7 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.98527947 |
| 8 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.90580449 |
| 9 | Phototransduction_Homo sapiens_hsa04744 | 1.86269017 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.82112658 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.80785957 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.77562014 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.77468047 |
| 14 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.76980164 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72237379 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.69664721 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.61626738 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.58427008 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.53232419 |
| 20 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.51984671 |
| 21 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.51649142 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.46813496 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.44958840 |
| 24 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.44515393 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.41625710 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.40717567 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.38244876 |
| 28 | Lysine degradation_Homo sapiens_hsa00310 | 1.36285953 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33897256 |
| 30 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.33427894 |
| 31 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.29508018 |
| 32 | Platelet activation_Homo sapiens_hsa04611 | 1.23872310 |
| 33 | Alcoholism_Homo sapiens_hsa05034 | 1.23506596 |
| 34 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.23485029 |
| 35 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.22335404 |
| 36 | Base excision repair_Homo sapiens_hsa03410 | 1.21327854 |
| 37 | Insulin resistance_Homo sapiens_hsa04931 | 1.19077386 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16407297 |
| 39 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.16062107 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15141629 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.13458520 |
| 42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13235753 |
| 43 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.12235846 |
| 44 | Olfactory transduction_Homo sapiens_hsa04740 | 1.08568048 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.07539224 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.07493494 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 1.06766511 |
| 48 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.05919674 |
| 49 | HTLV-I infection_Homo sapiens_hsa05166 | 1.05724102 |
| 50 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.05470930 |
| 51 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.04802707 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02782789 |
| 53 | Glioma_Homo sapiens_hsa05214 | 1.02609087 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.00369193 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97816405 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.96892563 |
| 57 | Asthma_Homo sapiens_hsa05310 | 0.96541193 |
| 58 | Long-term potentiation_Homo sapiens_hsa04720 | 0.96277469 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95783154 |
| 60 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95736509 |
| 61 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90838817 |
| 62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.90408783 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86802011 |
| 64 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86678579 |
| 65 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.86037375 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84611697 |
| 67 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.84230128 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83696844 |
| 69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.82948567 |
| 70 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82921342 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 0.82843847 |
| 72 | Colorectal cancer_Homo sapiens_hsa05210 | 0.82647282 |
| 73 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.81742606 |
| 74 | DNA replication_Homo sapiens_hsa03030 | 0.80234082 |
| 75 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.78203693 |
| 76 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78097418 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.75897686 |
| 78 | Tuberculosis_Homo sapiens_hsa05152 | 0.75543187 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.74375315 |
| 80 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74135442 |
| 81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.73941952 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.73898811 |
| 83 | Influenza A_Homo sapiens_hsa05164 | 0.73679149 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.70838404 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69811501 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69508585 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67721669 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.66960143 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66679637 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65325658 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65304979 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.64801069 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63600458 |
| 94 | Cell cycle_Homo sapiens_hsa04110 | 0.63302360 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62490505 |
| 96 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61334158 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.61122914 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59636262 |
| 99 | Pertussis_Homo sapiens_hsa05133 | 0.58354992 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57277457 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57059547 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.55381281 |
| 103 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.54782941 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54720235 |
| 105 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54469465 |
| 106 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53888207 |
| 107 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53381817 |
| 108 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52802876 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51982134 |
| 110 | Hepatitis C_Homo sapiens_hsa05160 | 0.51643254 |
| 111 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51159675 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50383763 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50217130 |
| 114 | Amoebiasis_Homo sapiens_hsa05146 | 0.49959272 |
| 115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49929842 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49339804 |
| 117 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48926623 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47986441 |
| 119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46450393 |
| 120 | Pathways in cancer_Homo sapiens_hsa05200 | 0.45391772 |
| 121 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45103338 |
| 122 | Mismatch repair_Homo sapiens_hsa03430 | 0.42932198 |
| 123 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.39761252 |
| 124 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.39566247 |
| 125 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38810054 |

